CD2AP and focal segmental glomerulosclerosis: A similar system was also used by the Potter group to determine specific changes in podocytes, mesangial cells and endothelial cells in Cd2ap-/—and Cd2ap+/-;Fyn-/—driven FSGS [9,10].